Mainz Biomed NV

詳細情報 Mainz Biomed NV 企業名

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

企業情報

企業コードMYNZ

会社名Mainz Biomed NV

上場日Nov 04, 2021

最高経営責任者「CEO」Mr. Guido Baechler

従業員数19

証券種類Ordinary Share

決算期末Nov 04

本社所在地Sirius Gutenberg Park

都市MAINZ

証券取引所NASDAQ Capital Market Consolidated

国Germany

郵便番号55129

電話番号4961315542860

ウェブサイトhttps://www.mainzbiomed.com/

企業コードMYNZ

上場日Nov 04, 2021

最高経営責任者「CEO」Mr. Guido Baechler

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Guido Baechler

Chief Executive Officer, Executive Director

20.06K

+6.65%

Mr. Hans Hekland

Non-Executive Independent Director

17.77K

-0.84%

Dr. Chris von Toerne

Chief Operating Officer

2.50K

+1379.29%

Dr. Heiner Dreismann, Ph.D.

Non-Executive Independent Director

2.20K

--

Mr. William Caragol

Chief Financial Officer

--

Mr. Gregory J. (Greg) Tibbitts

Non-Executive Independent Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Guido Baechler

Chief Executive Officer, Executive Director

20.06K

+6.65%

Mr. Hans Hekland

Non-Executive Independent Director

17.77K

-0.84%

Dr. Chris von Toerne

Chief Operating Officer

2.50K

+1379.29%

Dr. Heiner Dreismann, Ph.D.

Non-Executive Independent Director

2.20K

--

Mr. William Caragol

Chief Financial Officer

--

Mr. Gregory J. (Greg) Tibbitts

Non-Executive Independent Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, Sep 6

株主統計

種類

株主統計

比率

Armistice Capital LLC

6.23%

Dauntless Investment Group, LLC

1.09%

Fur Wiederaufbau (Kredianstalt)

0.51%

Baechler (Guido)

0.44%

Hekland (Hans)

0.39%

他の

91.35%

株主統計

比率

Armistice Capital LLC

6.23%

Dauntless Investment Group, LLC

1.09%

Fur Wiederaufbau (Kredianstalt)

0.51%

Baechler (Guido)

0.44%

Hekland (Hans)

0.39%

他の

91.35%

種類

株主統計

比率

Hedge Fund

6.23%

Investment Advisor

2.18%

Individual Investor

1.63%

Research Firm

0.03%

他の

89.94%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

35

323.69K

7.07%

-4.46K

2025Q1

40

350.55K

9.90%

-3.02K

2024Q4

40

356.23K

16.03%

+257.88K

2024Q3

37

115.45K

5.70%

+19.26K

2024Q2

34

120.95K

9.96%

+24.53K

2024Q1

36

122.04K

10.26%

+25.33K

2023Q4

27

96.56K

23.08%

+9.46K

2023Q3

22

91.42K

24.64%

+4.27K

2023Q2

22

91.39K

24.65%

+4.22K

2023Q1

19

86.84K

24.47%

+12.12K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Armistice Capital LLC

196.60K

5.15%

-25.40K

-11.44%

Mar 31, 2025

Fur Wiederaufbau (Kredianstalt)

23.20K

0.61%

-7.74K

-25.00%

Sep 30, 2024

Baechler (Guido)

20.06K

0.53%

+1.25K

+6.65%

Mar 21, 2025

Hekland (Hans)

17.77K

0.47%

-151.00

-0.84%

Mar 21, 2025

Steward Partners Investment Advisory, LLC

1.00K

0.03%

+1.00K

--

Mar 31, 2025

UBS Financial Services, Inc.

1.91K

0.05%

-1.85K

-49.20%

Mar 31, 2025

Caragol (William J)

7.90K

0.21%

+2.58K

+48.56%

Mar 21, 2025

詳細を見る

1.610USD

Mainz Biomed NV

1.610

概要

企業名

金融

分析